Page last updated: 2024-10-24

camostat and Experimental Neoplasms

camostat has been researched along with Experimental Neoplasms in 2 studies

camostat : A benzoate ester resulting from the formal condensation of the carboxy group of 4-guanidinobenzoic acid with the hydroxy group of 2-(dimethylamino)-2-oxoethyl (4-hydroxyphenyl)acetate. It is a potent inhibitor of the human transmembrane protease serine 2 (TMPRSS2) and its mesylate salt is currently under investigation for its effectiveness in COVID-19 patients.

Research Excerpts

ExcerptRelevanceReference
" This drug at a dosage of 10 mg/kg or 20 mg/kg was administered by ip injection to 20 mice each harboring a solitary tumor twice daily for 10 weeks."1.26Inhibition of growth of 3-methylcholanthrene-induced mouse skin tumor by protease inhibitor [N,N-dimethylcarbamoylmethyl 4-(4-guanidinobenzoyloxy)-phenylacetate] methanesulfate. ( Ohkoshi, M, 1981)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ohkoshi, M2
Fujii, S1

Other Studies

2 other studies available for camostat and Experimental Neoplasms

ArticleYear
Effect of oral administration of protease inhibitor [N,N-dimethylcarbamoylmethyl 4-(4-guanidinobenzoyloxy)-phenylacetate] methanesulfate on the growth of 3-methylcholanthrene-induced carcinoma in mice.
    Gan, 1982, Volume: 73, Issue:1

    Topics: Animals; Carcinoma, Squamous Cell; Cell Division; Esters; Female; Gabexate; Guanidines; Methylcholan

1982
Inhibition of growth of 3-methylcholanthrene-induced mouse skin tumor by protease inhibitor [N,N-dimethylcarbamoylmethyl 4-(4-guanidinobenzoyloxy)-phenylacetate] methanesulfate.
    Gan, 1981, Volume: 72, Issue:6

    Topics: Animals; Body Weight; Carcinoma, Squamous Cell; Cell Division; Drug Evaluation, Preclinical; Esters;

1981